Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study

BACKGROUND: Research has revealed that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) may prevent cancers such as hepatocellular carcinoma (HCC). The comparative chemopreventive effects of ACEIs and ARBs in high-risk populations with hepatitis B virus (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Cheng-Maw, Lee, Chih-Hsin, Lee, Ming-Chia, Zhang, Jun-Fu, Wang, Jann-Yuan, Hu, Rey-Heng, Lee, Po-Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891974/
https://www.ncbi.nlm.nih.gov/pubmed/29631561
http://dx.doi.org/10.1186/s12885-018-4292-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891974/
https://www.ncbi.nlm.nih.gov/pubmed/29631561
http://dx.doi.org/10.1186/s12885-018-4292-y

Ejemplares similares